| Effect of Bevacizumab Plus Temozolomide-Radiotherapy for Newly Diagnosed Glioblastoma with Different MGMT Methylation Status: A Meta-Analysis of Clinical Trials | |
| Du, Chigang; Ren, Junquan; Zhang, Rui; Xin, Tao; Li, Zhongmin; Zhang, Zhiti; Xu, Xinghua; Pang, Qi | |
| 刊名 | MEDICAL SCIENCE MONITOR
 |
| 2016 | |
| 卷号 | 22页码:3486-3492 |
| 关键词 | Chemoradiotherapy Disease-Free Survival Glioblastoma |
| DOI | 10.12659/MSM.899224 |
| URL标识 | 查看原文 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/4689403 |
| 专题 | 山东大学 |
| 作者单位 | 1.Shandong Univ, Prov Hosp, Dept Neurosurg, Jinan, Shandong, Peoples R China. 2.[Du, Chigang 3.Li, Zhongmi |
| 推荐引用方式 GB/T 7714 | Du, Chigang,Ren, Junquan,Zhang, Rui,et al. Effect of Bevacizumab Plus Temozolomide-Radiotherapy for Newly Diagnosed Glioblastoma with Different MGMT Methylation Status: A Meta-Analysis of Clinical Trials[J]. MEDICAL SCIENCE MONITOR,2016,22:3486-3492. |
| APA | Du, Chigang.,Ren, Junquan.,Zhang, Rui.,Xin, Tao.,Li, Zhongmin.,...&Pang, Qi.(2016).Effect of Bevacizumab Plus Temozolomide-Radiotherapy for Newly Diagnosed Glioblastoma with Different MGMT Methylation Status: A Meta-Analysis of Clinical Trials.MEDICAL SCIENCE MONITOR,22,3486-3492. |
| MLA | Du, Chigang,et al."Effect of Bevacizumab Plus Temozolomide-Radiotherapy for Newly Diagnosed Glioblastoma with Different MGMT Methylation Status: A Meta-Analysis of Clinical Trials".MEDICAL SCIENCE MONITOR 22(2016):3486-3492. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论